FindTrial
Sign In

Effectiveness and Safety of Oral Progesterone Tablet NMP SR 400 mg for Hormonal Support After Egg Collection in Women Undergoing IVF with Freeze-All Strategy

A Single Arm Observational Study Evaluating NMP SR Oral Tablets for Luteal Phase Support and Pregnancy Outcomes in IVF Cycles Using GnRH Agonist Trigger and Freeze All Strategy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/105219
Enrollment
50
Registered
2026-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Kundan V Ingale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women aged 18 to 38 years Undergoing IVF or ICSI with GnRH agonist trigger Freeze all cycle strategy AMH more than equal to 1.2 ng per mL No allergy to progesterone Written informed consent obtained

Exclusion criteria

Exclusion criteria: Uncorrected uterine or endometrial abnormality Medications affecting progesterone metabolism Severe hepatic impairment Concurrent interventional trial participation Planned use of another progesterone formulation

Design outcomes

Primary

MeasureTime frame
Proportion of participants achieving serum progesterone within target range of 7 to 20 ng per mLTimepoint: Days 5 8 11 and 14 post oocyte retrieval—

Secondary

MeasureTime frame
Endometrial thickness in mmTimepoint: Day 8 post oocyte retrieval;Trilaminar endometrial morphologyTimepoint: Day 11 post oocyte retrieval;Clinical Pregnancy RateTimepoint: 6 weeks gestation confirmed by Ultrasound;Ongoing pregnancy rateTimepoint: 20 Weeks gestation;Live Birth RateTimepoint: At delivery;Incidence & nature of Adverse eventsTimepoint: From initiation of NMP SR until Day 14 post oocyte retrieval—

Countries

India

Contacts

Public ContactDr Kundan V Ingale

Nirmiti Clinic

drkingale@yahoo.com09168898823

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026